Abstract
Initial clinical research comparing the diagnostic performance of Positron Emission Tomography (PET)/ Magnetic Resonance Imaging (MRI) and PET/ Computed Tomography (PET/CT) has largely shown equivalent diagnostic capabilities for these modalities in oncology. These uncertainties about the magnitude of diagnostic benefit are compounded by the considerable health economic challenges associated with clinical implementation. Therefore, there is a need to identify ways to extend the use of this technology beyond simple diagnosis so that PET/MRI can add sufficient clinical value beyond PET/CT or MRI alone, and become a cost-effective imaging modality in clinical practice. A major advantage of PET/MRI over other imaging modalities is the ability to generate multiple quantitative images from a single examination. This article describes how a multi-parametric PET/MRI approach can not only add clinical value through contributing to precision medicine but also establish PET/MRI as a potentially cost-effective imaging modality in oncology.
- Molecular Imaging
- Oncology: General
- PET/MRI
- Other
- Oncology
- Positron Emission Tomography/Magnetic Resonance Imaging
- Precision Medicine
- Copyright © 2018 by the Society of Nuclear Medicine and Molecular Imaging, Inc.